General


Peptide: BMAP-28
Microorganism:Stenotrophomonas maltophilia
Administration:
Stage: Formation (3-24h)
Notes:Sm109 clinical isolate

Experimental procedure


Method AMP Effect(Biofilm reduction) Concentration Notes
Crystal violet assay 21 - 50% 2.603 uM
Crystal violet assay <= 20 % 1.302 uM
Crystal violet assay Not Active 0.651 uM

Reference



M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.

Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or giuseppe.maccari@iit.it